Rare Medical News

Advertisement

Spotlight On

Duane Syndrome

Duane Syndrome is a rare disorder described in the medical literature with low prevalence and variable expression.

Prevalence

10 / 10 000

10–20

US Estimated

10–20

Europe Estimated

Age of Onset

Congenital - Childhood

ageofonset infancy https://raremedicalnews.com/wp-content/uploads/2024/03/Depositphotos_93822642_L.jpg

ICD-10

H50.81

Inheritance Pattern

Autosomal dominant

in some cases

rnn autosomaldominant https://raremedicalnews.com/wp-content/uploads/2024/03/Depositphotos_93822642_L.jpg

Autosomal recessive

no https://raremedicalnews.com/wp-content/uploads/2024/03/Depositphotos_93822642_L.jpg

Mitochondrial/Multigenic

no https://raremedicalnews.com/wp-content/uploads/2024/03/Depositphotos_93822642_L.jpg

X-linked dominant

no https://raremedicalnews.com/wp-content/uploads/2024/03/Depositphotos_93822642_L.jpg

X-linked recessive

no https://raremedicalnews.com/wp-content/uploads/2024/03/Depositphotos_93822642_L.jpg

Rare View

Duane Syndrome is a rare congenital eye condition that affects the movement of one or both eyes. It is caused by abnormal development or miswiring of the nerves controlling the eye muscles, particularly the sixth cranial nerve.

 
rv duane syndrome https://raremedicalnews.com/wp-content/uploads/2024/03/Depositphotos_93822642_L.jpg

5 Facts you should know

FACT

1

Duane Syndrome is a congenital eye movement disorder characterized by limited or absent horizontal eye movement and abnormal retraction or widening of the eye fissure upon attempted inward gaze

FACT

2

It results from aberrant development of the abducens (VI) and oculomotor (III) cranial nerves during early embryogenesis, leading to inadequate innervation of the lateral rectus muscle and inappropriate connections with the medial rectus muscle

FACT

3

There are three subtypes: Type 1, characterized by limited abduction; Type 2, featuring limited adduction; and Type 3, displaying limited abduction and adduction, with varying severity

FACT

4

Duane Syndrome may occur unilaterally or bilaterally, often associated with abnormal head posture or compensatory head movements to improve vision

FACT

5

Diagnosis involves clinical examination, assessing ocular motility, cranial nerve function, and associated anomalies, often requiring periodic ophthalmologic evaluation during childhood

Duane Syndrome is also known as...

Duane Syndrome is also known as:

  • Duane retraction syndrome

  • Stilling–Türk–Duane syndrome

What’s your Rare IQ?

What is the primary cause of Duane syndrome?

Common signs & symptoms

Limitation of horizontal ductions

Globe retraction and narrowing of palpebral fissure on adduction

Upshoots/downshoots on attempted adduction due to co-contraction and slippage

Strabismus in primary position and abnormal head posture to maintain binocular single vision

Some patients develop amblyopia, anisometropia, or diplopia

Current treatments

Non-surgical management

  • Correct refractive error; amblyopia therapy when present. 
  • Prisms may help in selected patients with small deviations and head posture. 

Surgery (indications and goals)

  • Primary indications: significant deviation in primary gaze and/or functionally important abnormal head posture. 
  • Additional goals: reduce cosmetically significant retraction and severe upshoot/downshoot. 
  • Surgery is tailored (muscle recession/transposition strategies) and aims to improve alignment and posture—not normalize innervation.

References:

Gutowski NJ, Chilton JK. The congenital cranial dysinnervation disorders. <i>Arch Dis Child.</i> 2015;100(7):678–681. doi:10.1136/archdischild-2014-307678 Huber A. Electrophysiology of the retraction syndromes. <i>Br J Ophthalmol.</i> 1974;58(3):293–300. doi:10.1136/bjo.58.3.293 Engle EC. The genetic basis of congenital strabismus. <i>Arch Ophthalmol.</i> 2007;125(2):189–195. doi:10.1001/archopht.125.2.189 Yamada K, Andrews C, Chan WM, et al. Heterozygous mutations of the CHN1 gene in Duane retraction syndrome. <i>Nat Genet.</i> 2003;35(4):318–321. doi:10.1038/ng1261

Clinical trials